CA
NZ
UK
AU
IND
US
Supernus Pharmaceuticals, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 3, 2026, disclosing its financial results for the second quarter ended June 30, 2026, and announcing a definitive all-stock merger agreement with Indivior Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) filed a current report on Form 8-K on August 3, 2026, disclosing a joint investor conference call and webcast with Indivior Pharmaceuticals Inc. regarding a proposed merger of the two companies.
Interactive Brokers Group, Inc. filed a Form 8-K on July 31, 2026, disclosing the filing of a Prospectus Supplement under Rule 424(b)(5) to register up to 920,000 shares of its common stock from an existing shelf Registration Statement.
UMB Financial Corporation disclosed its second quarter 2026 financial results in a regulatory filing dated July 30, 2026. The company, which operates through multiple banking segments including consumer, commercial, and institutional banking divisions, provided detailed information on its credit portfolio composition, deposit accounts, and …
Marcus Theatres (NYSE: MCS) disclosed financial results for the second quarter ended June 30, 2026, covering the period from April 1 through June 30, 2026. The company operates through theatre operations and hotels and resorts segments, generating revenue from admission, occupancy, concessions, food and …
Ranpak Holdings Corp. disclosed its second quarter 2026 financial results on July 30, 2026, through a formal announcement and scheduled conference call. The company, which manufactures protective packaging solutions, reported earnings for the three-month period ended June 30, 2026. Investors will have access to …
Medical Logistics Inc. (NASDAQ: MDGL) filed its second-quarter 2026 financial results on July 30, 2026, covering the period ended June 30, 2026. The disclosure includes balance sheet data, equity composition, and details on the company's financing arrangements. The filing provides investors with an updated …
Ranpak Holdings, a NYSE-listed packaging solutions provider, disclosed its second quarter 2026 financial results in a regulatory filing dated July 30, 2026. The company operates through two geographic segments—North America and Europe and Asia—and maintains a diversified customer base including one significant customer relationship. …
Entertainment Properties Trust disclosed its second-quarter 2026 financial performance in a filing dated July 29, 2026. The real estate investment trust, which holds experiential and fitness properties, reported results for the six-month period ending June 30, 2026. The disclosure includes balance sheet data, capital …
Crescent Biopharma, Inc. filed a prospectus supplement on July 30, 2026, updating its securities registration to reflect the company's most recent quarterly financial results for the period ended June 30, 2026. The update covers the resale of approximately 19.6 million ordinary shares by selling …
Please wait processing your request...